alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**EXHIBIT 31.1**

**CERTIFICATIONS**

I, Richard E. Otto, certify that: 

1. I have reviewed this Annual Report on Form 10-K of Corautus Genetics Inc.; 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make thestatements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of theregistrant as of, and for, the periods presented in this report; 

4. The registrant’s other certifying officer(s) and I areresponsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under oursupervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Reserved; 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the endof the period covered by this report based on such evaluation; and 

(d) Disclosed in this report any change in theregistrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or isreasonably likely to materially affect, the registrant’s internal control over financial reporting; and 

5. The registrant’sother certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or personsperforming the equivalent functions): 

(a) All significant deficiencies and material weaknesses in the design or operationof internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’sinternal control over financial reporting. 

Date: March 30, 2007
# Comments on: 20-2251: SHOCKWAVE MEDICAL, INC. v. CARDIOVASCULAR SYSTEMS, INC. [RULE 36 JUDGMENT], Nonprecedential
Exhibit
10.10


 


AMERICAN
POWER GROUP CORPORATION


 


2016
STOCK OPTION PLAN


 


Amendment
No. 1


 


Adopted
by the Board of Directors on January 16, 2017


 


1.       Section
4 of the 2016 Stock Option Plan (the “Plan”) of American Power Group Corporation (the “Company”) is hereby
amended in its entirety to read as follows:


 


4.       Stock.
The stock subject to Options shall be authorized but unissued shares of Common Stock of the Company, par value $.01 per share
(the “Common Stock”), or shares of Common Stock reacquired by the Company in any manner. The aggregate number of shares
which may be issued pursuant to the Plan is 90,000,000, subject to adjustment as provided in paragraph 13. Any such shares may
be issued as ISOs or Non-Qualified Options so long as the number of shares so issued does not exceed such number, as adjusted.
If any Option granted under the Plan shall expire or terminate for any reason without having been exercised in full or shall cease
for any reason to be exercisable in whole or in part, the unpurchased shares subject to such Options shall again be available
for grants of Option under the Plan. The number of shares of Common Stock in respect of which an optionee may receive Options
under the Plan in any year shall not exceed 6,000,000 shares, subject to adjustment as provided in paragraph 13.


 


2.       The
amendment to the Plan set forth in Section 1, above, shall become effective if and only if the Company’s stockholders approve
such amendment within twelve months after January 16, 2017, as required by Section 422 of the Internal Revenue Code of 1986, as
amended. The Company shall not grant options to purchase more than an aggregate of 21,000,000 shares of Common Stock under the
Plan prior to such approval unless such grants, and the stock option agreements relating thereto, expressly provide that such
grants shall be rescinded if such approval is not timely received.
UNITED STATES DISTRICT COURT

SOUTHERN DISTRICT OF FLORIDA

MIAMI DIVISION

CASE NO. 22-cv-24023-SCOLA/GOODMAN

KENNETH C. GRIFFIN,

Plaintiff,

v.

INTERNAL REVENUE SERVICE and U.S.

DEPARTMENT OF THE TREASURY,

Defendants.

_______________________________________/

POST-DISCOVERY HEARING ADMINISTRATIVE ORDER1

On March 8, 2024, the Undersigned held a Zoom videoconference hearing on the 

parties’ discovery disputes. [ECF Nos. 92; 93; 95–97]. At the hearing, the Undersigned 

ordered as follows:

The parties will proceed with Charles Edward Littlejohn’s deposition as scheduled 

on March 19, 2024. In the meantime, the Government will continue producing additional 

1 This written Order includes an additional requirement not mentioned during the 

Court’s ore tenus ruling.

Case 1:22-cv-24023-RNS Document 99 Entered on FLSD Docket 03/08/2024 Page 1 of 3
2

documents on a rolling basis up to and including the date of Mr. Littlejohn’s deposition.

The Court appreciates the magnitude of the effort being made by the 

Government’s attorneys. Nonetheless, the Government’s team will need to continue 

working diligently on their document production through March 19, 2024. During the 

time period leading up to (and including) Mr. Littlejohn’s deposition, the Court does not 

expect any lesser efforts being made and, to the extent possible, the Government should 

increase its efforts by adding hours or attorneys to the schedule.

At the deposition, Plaintiff will be able to find out from Mr. Littlejohn whether or 

not there are certain additional documents which exist, or likely could exist, which have 

not yet been produced.

If Plaintiff wishes to obtain additional relief which would require the Government 

to resume its document production efforts past March 19, 2024, then Plaintiff will need to 

cite (page and line) to testimony from Mr. Littlejohn’s deposition and any additional 

theories which might implicate the relevance of any continued discovery. In other words, 

after March 19, 2024, the Government may cease its document production and will not 

need to start it up again unless and until Plaintiff can demonstrate to the Court through 

Mr. Littlejohn’s deposition testimony why the Court should require the Government to 

resume its document production.

By March 18, 2024, the Government shall submit an affidavit or declaration from 

an appropriate IRS attorney explaining in detail how many lawyers were working on the 

Case 1:22-cv-24023-RNS Document 99 Entered on FLSD Docket 03/08/2024 Page 2 of 3
3

ESI discovery response and the number of days and hours they worked from March 8, 

2024 through the date of the affidavit or declaration.

DONE AND ORDERED in Chambers, in Miami, Florida, on March 8, 2024.

Copies furnished to:

The Honorable Robert N. Scola, Jr.

All Counsel of Record

Case 1:22-cv-24023-RNS Document 99 Entered on FLSD Docket 03/08/2024 Page 3 of 3
#### § 301-11.19 How is my per diem calculated when I travel across the international dateline (IDL)?

When you cross the IDL your actual elapsed travel time will be used to compute your per diem entitlement rather than calendar days.
#### § 302-9.13 May my agency determine that driving my POV is more advantageous and limit my reimbursement to what it would cost to drive my POV?

Yes, your agency decides whether it is more advantageous for you and/or a member of your immediate family to drive your POV for all or part of the distance or to have it transported. If your agency decides that driving the POV is more advantageous, your reimbursement will be limited to the allowances provided in part 302-4 of this chapter for the travel and transportation expenses you and/or your immediate family incur en route.

[FTR Amdt. 98, 66 FR 58196, Nov. 20, 2001. Redesignated by FTR Amdt. 2011-06, 76 FR 71889, Nov. 21, 2011]
§ 105-68.610 What procedures does the General Services Administration use in suspension and debarment actions? In deciding whether to suspend or debar you, we handle the actions as informally as practicable, consistent with principles of fundamental fairness. ( a ) For suspension actions, we use the procedures in this subpart and subpart G of this part.
( b ) For debarment actions, we use the procedures in this subpart and subpart H of this part.
§ 302-11.4 Who is not eligible to receive an allowance for expenses incurred in connection with residence transactions? You are not eligible to receive an allowance for expenses incurred in connection with residence transactions under this subpart if you are: ( a ) A new appointee; or
( b ) An employee assigned under the Government Employees Training Act (5 U.S.C. 4109).
#### § 301-51.2 Are there any official travel expenses that are exempt from the mandatory use of the Government contractor-issued travel charge card?

Expenses for which payment through the Government contractor-issued travel charge card is impractical (*e.g.,* vendor does not accept credit cards) or imposes unreasonable burdens or costs (*e.g.,* fees are charged for using the card) are exempt from use of the travel charge card. Your agency may also exempt an official travel expense when it is necessary in the interest of the agency (see § 301-51.4).

[FTR Amdt. 2016-01, 81 FR 63138, Sept. 14, 2016]
#### § 109-27.5100 Scope of subpart.

This subpart provides policies, principles, and guidelines to be used in the management of purchased and recovered precious metals used to meet research, development, production, and other programmatic needs.
#### § 301-31.2 What is “family” with respect to threatened law enforcement/investigative employees?

Generally, “family” includes any member of your immediate family, as defined in § 300-3.1 of this title. However, your agency may, on a case-by-case basis, expand this definition to include other members of you and/or your spouse's or domestic partner's extended family.

[FTR Amdt. 70, 63 FR 15966, Apr. 1, 1998, as amended by FTR Amdt. 2010-06, 75 FR 67631, Nov. 3, 2010]
<TABLE> <S> <C>

<ARTICLE>            5
       
<S>                           <C>
<PERIOD-TYPE>                 3-MOS
<FISCAL-YEAR-END>                        DEC-28-1997
<PERIOD-START>                           DEC-30-1996
<PERIOD-END>                             MAR-30-1997
<CASH>                                   30,415
<SECURITIES>                             0
<RECEIVABLES>                            296,716
<ALLOWANCES>                             0
<INVENTORY>                              148,011
<CURRENT-ASSETS>                         609,654
<PP&E>                                   332,411
<DEPRECIATION>                           114,958
<TOTAL-ASSETS>                           1,053,155
<CURRENT-LIABILITIES>                    260,154
<BONDS>                                  175,235
<PREFERRED-MANDATORY>                    0
<PREFERRED>                              0
<COMMON>                                 892
<OTHER-SE>                               412,268
<TOTAL-LIABILITY-AND-EQUITY>             1,053,155
<SALES>                                  253,450
<TOTAL-REVENUES>                         253,450
<CGS>                                    185,669
<TOTAL-COSTS>                            185,669
<OTHER-EXPENSES>                         0
<LOSS-PROVISION>                         0
<INTEREST-EXPENSE>                       1,993
<INCOME-PRETAX>                          32,637
<INCOME-TAX>                             12,076
<INCOME-CONTINUING>                      20,561
<DISCONTINUED>                           (13,713)
<EXTRAORDINARY>                          0
<CHANGES>                                0
<NET-INCOME>                             6,848
<EPS-PRIMARY>                            .08
<EPS-DILUTED>                            .08
        

</TABLE>
#### § 302-11.430 When must we reimburse an employee for expenses incurred due to settlement of an unexpired lease?

You must reimburse an employee in lieu of residence transaction expenses when the employee meets the requirements of § 302-11.10 for expenses incurred due to settlement of an unexpired lease.
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JAN-31-1998
<PERIOD-END>                               JUL-26-1997
<CASH>                                           17548
<SECURITIES>                                         0
<RECEIVABLES>                                    26386
<ALLOWANCES>                                         0
<INVENTORY>                                     443827
<CURRENT-ASSETS>                                502928
<PP&E>                                          114147
<DEPRECIATION>                                   38168
<TOTAL-ASSETS>                                  587171
<CURRENT-LIABILITIES>                           383422
<BONDS>                                          33982
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           218
<OTHER-SE>                                      112790
<TOTAL-LIABILITY-AND-EQUITY>                    587171
<SALES>                                         503567
<TOTAL-REVENUES>                                510820
<CGS>                                           357219
<TOTAL-COSTS>                                   357219
<OTHER-EXPENSES>                                139207
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                3263
<INCOME-PRETAX>                                  11186
<INCOME-TAX>                                      3808
<INCOME-CONTINUING>                               7378
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      7378
<EPS-PRIMARY>                                      .31
<EPS-DILUTED>                                      .31
        

</TABLE>
Exhibit 99.1


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Wyeth (the "Company") on Form 10-Q
for the fiscal quarter ended September 30, 2002, as filed with the Securities
and Exchange Commission on November 13, 2002 (the "Report"), I, Robert Essner,
Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. ss. 1350,
as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

Dated: November 13, 2002

                                        By /s/   Robert Essner
                                           ----------------------------------
                                                 Robert Essner
                                        President and Chief Executive Officer
119PA15

#### In the Matter of N.T.

Guardian *ad Ldtem’s*Motion to Substitute Counsel

Allowed 12/02/2015
H. R. 416

One Hundred Third Congress

of the

United States of America

AT THE FIRST SESSION

Begun and held at the City of Washington on Tuesday,

the fifth day of January, one thousand nine hundred and ninety-three

An Act

To extend the period during which chapter 12 of title 11 of the United States

Code remains in effect, and for other purposes.

Be it enacted by the Senate and House of Representatives of

the United States of America in Congress assembled,

SECTION 1. EXTENSION OF TIME PERIOD.

The first sentence of section 302(f) of the Bankruptcy Judges,

United States Trustees, and Family Farmer Bankruptcy Act of

1986 (Public Law 99–554; 100 Stat. 3124) is amended by striking

‘‘1993’’ and inserting ‘‘1998’’.

SEC. 2. FILING OF PLAN.

Section 1221 of title 11, United States Code, is amended by

striking ‘‘an extension is substantially justified’’ and inserting ‘‘the

need for an extension is attributable to circumstances for which

the debtor should not justly be held accountable’’.

SEC. 3. EFFECTIVE DATE; APPLICATION OF AMENDMENT MADE BY

SECTION 2.

(a) EFFECTIVE DATE.—Except as provided in subsection (b),

this Act and the amendments made by this Act shall take effect

on the date of the enactment of this Act.

(b) APPLICATION OF AMENDMENT MADE BY SECTION 2.—The

amendment made by section 2 shall not apply with respect to

cases commenced under title 11 of the United States Code before

the date of the enactment of this Act.

Speaker of the House of Representatives.

Vice President of the United States and

President of the Senate.

17:56 Aug 04, 1993 VerDate 01-JUL-93 Jkt 059200 PO 00000 Frm 00001 Fmt 6655 Sfmt 6501 E:\BILLS\H416.ENR bend06
#### § 102-75.355 What clause must be in the offer to purchase and the conveyance documents for public benefit conveyances?

Executive agencies must include in the offer to purchase and conveyance documents the non-discrimination clause in § 102-75.360 for public benefit conveyances.
#### § 109-45.304 Sales methods and procedures.
Exhibit 10.19
 SECOND AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE
 Amendment" Investor Company" Party Parties 
 1.
    
    Amendment of Note. The Parties hereby agree to amend that certain Promissory Note,
dated March 26, 2010, made and issued by the Company to Investor under that certain Note and
Warrant Purchase Agreement dated as of March 26, 2010, which Promissory Notes were amended and
restated on November 15, 2010 and amended on January 14, 2011 (as amended, restated,
supplemented or otherwise modified from time to time, the Note), as follows: the phrase
June 30, 2011 in subclause (i) of Section 4 of the Note is hereby deleted in its entirety
and replaced with September 30, 2011.2.
    
    Survival. Except as expressly modified hereby, all of the provisions of the Note
remain in full force and effect and shall be unaffected by this Amendment.3.
    
    Execution in Counterparts. This Amendment may be executed in one or more
counterparts, each of which shall be deemed an original but all of which together will
constitute one and the same instrument. This Amendment or any counterpart may be executed and
delivered by facsimile or email with scan attachment copies or pdf, each of which shall be
deemed an original.
 Signature Page Follows
  1




---



##### 



COMPANY:VIA PHARMACEUTICALS, INC.By: /s/ Karen S. WrightName: Karen S. WrightTitle: VP Finance, ControllerAddress:VIA Pharmaceuticals, Inc.750 Battery Street, Suite 330San Francisco, California 94111Attention: Vice President, ControllerFacsimile: (415) 283-2214Electronic mail:Karen.Wright@viapharmaceuticals.com
 [Signature page to Note Amendment]




---



##### 



INVESTOR:BAY CITY CAPITAL FUND IV, L.P.By: Bay City Capital Management IV LLC, itsgeneral partnerBy: Bay City Capital LLC, its managerBy: /s/ Fred CravesName: Fred CravesTitle: Managing DirectorAddress:Bay City Capital Fund IV, L.P.750 Battery Street, Suite 400San Francisco, California 94111Attention: Managing DirectorFacsimile:Electronic mail:
 [Signature page to Note Amendment]
[Federal Register Volume 65, Number 15 (Monday, January 24, 2000)]
[Notices]
[Page 3653]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-1600]


=======================================================================
-----------------------------------------------------------------------

COMMISSION ON CIVIL RIGHTS


Agenda and Notice of Public Meeting of the North Carolina 
Advisory Committee

    Notice is hereby given, pursuant to the provisions of the rules and 
regulations of the U.S. Commission on Civil Rights, that a meeting of 
the North Carolina Advisory Committee to the Commission will convene at 
1:00 p.m. and adjourn at 5:00 p.m. on February 9, 2000, at the North 
Carolina A&T State University, Hodgin Hall, Room 106, Greensboro, North 
Carolina 27411. The purpose of the meeting is to finalize a project 
proposal and to review civil rights issues.
    Persons desiring additional information, or planning a presentation 
to the Committee, should contact Bobby D. Doctor, Director of the 
Southern Regional Office, 404-562-7000 (TDD 404-562-7004). Hearing-
impaired persons who will attend the meeting and require the services 
of a sign language interpreter should contact the Regional Office at 
least ten (10) working days before the scheduled date of the meeting.
    The meeting will be conducted pursuant to the provisions of the 
rules and regulations of the Commission.

    Dated at Washington, DC, January 11, 2000.
Carol-Lee Hurley,
Chief, Regional Programs Coordination Unit.
[FR Doc. 00-1600 Filed 1-21-00; 8:45 am]
BILLING CODE 6335-01-P
§ 109-38.204-1 Unlimited exemptions. ( a ) - ( f ) [Reserved]
( g ) The Office of Management and Program Secretarial Officer (PSO) for their respective organizations may approve exemptions from the requirement for the display of U.S. Government license tags and other official identification for motor vehicles used for security or investigative purposes.